SS
ORMP icon

SBI Securities’s Oramed Pharmaceuticals ORMP Stock Holding History

SBI Securities’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284 Hold
59
– – ﹤0.01% 3216
2026
Q1 		$201 Sell
59
-1,531
-96% -$5.19K ﹤0.01% 3215
2025
Q4 		$4.53K Hold
1,590
– – ﹤0.01% 2054
2025
Q3 		$4.2K Sell
1,590
-45
-3% -$99 ﹤0.01% 2119
2025
Q2 		$3.68K Hold
1,635
– – ﹤0.01% 2134
2025
Q1 		$3.5K Sell
1,635
-5
-0.3% -$12 ﹤0.01% 2045
2024
Q4 		$3.97K Buy
+1,640
New +$3.9K ﹤0.01% 2014

Other funds holding ORMP

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
SCM
Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $194M AUM

SBI Securities's ORMP Position: Q2 2026 in Review

SBI Securities held its Oramed Pharmaceuticals (ORMP) position steady in Q2 2026 at 59 shares worth $284. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

SBI Securities first reported a position in ORMP in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.53K in Q4 2025. 14 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • SBI Securities held 59 shares of Oramed Pharmaceuticals worth $284 as of Q2 2026.
  • SBI Securities left its Oramed Pharmaceuticals share count unchanged in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3216 holding.
  • SBI Securities first reported a position in Oramed Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Oramed Pharmaceuticals position peaked at $4.53K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.